Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 30;10(42):25046-25058.
doi: 10.1039/d0ra04559d. eCollection 2020 Jun 29.

Novel quercetin and apigenin-acetamide derivatives: design, synthesis, characterization, biological evaluation and molecular docking studies

Affiliations

Novel quercetin and apigenin-acetamide derivatives: design, synthesis, characterization, biological evaluation and molecular docking studies

Daniel Isika et al. RSC Adv. .

Abstract

Flavonoids exhibit essential but limited biological properties which can be enhanced through chemical modifications. In this study, we designed, synthesized, and characterized two novel flavonoid derivatives, quercetin penta-acetamide (1S3) and apigenin tri-acetamide (2S3). These compounds were confirmed using (1H, 13C) NMR, UV-Vis, and FT-IR characterizations. Their interaction with fish sperm DNA (FS-DNA) at physiological pH was investigated by UV-Vis and fluorescence spectrophotometry. The binding constant (K b) for the UV-Vis experiment was found to be 1.43 ± 0.3 × 104 M-1 for 1S3 and 2.08 ± 0.2 × 104 M-1 for 2S3. The binding constants (K SV) for the fluorescence quenching experiment were 1.83 × 104 M-1 and 1.96 × 104 M-1 for 1S3 and 2S3, respectively. Based on molecular modeling and docking studies, the binding affinities were found to be -7.9 and -9.1 kcal mol-1, for 1S3 and 2S3, respectively. The compound-DNA docked model correlated with our experimental results, and they are groove binders. Furthermore, mutagenicity potential was examined. 1S3 and its metabolites showed no mutagenic activity for both TA98 and TA100 strains. 2S3 did not show any mutagenic activity for the strain TA 98, while its metabolites were only active at high doses. Both 2S3 and its metabolites showed mutagenic activity in the TA100 strain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Structure of apigenin and quercetin.
Fig. 2
Fig. 2. General structure of the flavonoids, the intermediates and the final products. R3, R5 and R7 variables are shown in Table 1.
Scheme 1
Scheme 1. Steps in the synthesis of 1S3 & 2S3 derivatives. Reagents and reaction conditions: step 1 (S0 → S1) ethyl chloroacetate, K2CO3 (excess), DMF, rt. Step 2 (S1 → S2) LiOH·H2O, THF/H2O, rt. Step 3 (S2 → S3) SOCl2 (excess), reflux, 75 °C; NH4OH (excess), 0 °C – rt.
Fig. 3
Fig. 3. Absorption spectra of 10 μmol L−1 1S3 and 2S3 in Tris–HCl buffer (0.1 mol L−1, pH 7.4).
Fig. 4
Fig. 4. Absorption spectra of 10 μmol L−1 1S3 (a) and 10 μmol L−1 2S3 (b) in the presence of FS-DNA at different concentrations (a: 0.0, b: 1.94, c: 3.89 d: 5.84, e: 7.78, f: 9.73, g: 11.68, h: 13.63, i: 15.58, and j: 17.52 μmol L−1 in Tris–HCl buffer (0.1 mol L−1, pH 7.4)). The inset showing the plot of [DNA/(εaεf)] versus [DNA].
Fig. 5
Fig. 5. Quenched Fluorescence spectra of FS-DNA bound to the EtBr system with the addition of compounds 1S3 (a) and 2S3 (b). Inset: I0/I versus [DNA] (μM).
Fig. 6
Fig. 6. Comparison graphs showing the changes in revertant colony percentages in the presence (+S9) and absence (−S9) of the metabolic activation system for TA98 and TA100 strains of compounds 1S3 and 2S3.
Fig. 7
Fig. 7. Molecular docked structure of 1S3 (a) and 2S3 (b) complexed with DNA. Surface representation showing the binding of 1S3 and 2S3 with the dodecamer duplex sequence, d(CGCGAATTCGCG)2 (PDB ID: 1BNA).
Fig. 8
Fig. 8. 2D plot of interaction between the 1S3 (a) and 2S3 (b) with the dodecamer duplex sequence, d(CGCGAATTCGCG)2 (PDB ID: 1BNA).

Similar articles

Cited by

References

    1. Ren W. Qiao Z. Wang H. Zhu L. Zhang L. Med. Res. Rev. 2003;23:519–534. doi: 10.1002/med.10033. - DOI - PubMed
    1. Cushnie T. P. T. Lamb A. J. Int. J. Antimicrob. Agents. 2011;38:99–107. doi: 10.1016/j.ijantimicag.2011.02.014. - DOI - PubMed
    1. De Conti Lourenço R. M., Da Silva Melo P. and De Almeida A. B. A., in Antifungal Metabolites from Plants, Springer-Verlag, Berlin Heidelberg, 2013, pp. 283–300
    1. García-Lafuente A. Guillamón E. Villares A. Rostagno M. A. Martínez J. A. Inflammation Res. 2009;58:537–552. doi: 10.1007/s00011-009-0037-3. - DOI - PubMed
    1. Panche A. N. Diwan A. D. Chandra S. R. J. Nutr. Sci. 2016;5(1) doi: 10.1017/jns.2016.41. - DOI - PMC - PubMed